WV HB4263 | 2018 | Regular Session
Status
Sponsorship: Bipartisan Bill
Status: Introduced on January 23 2018 - 25% progression, died in committee
Action: 2018-01-23 - To House Prevention and Treatment of Substance Abuse
Pending: House Prevention and Treatment of Substance Abuse Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on January 23 2018 - 25% progression, died in committee
Action: 2018-01-23 - To House Prevention and Treatment of Substance Abuse
Pending: House Prevention and Treatment of Substance Abuse Committee
Text: Latest bill text (Introduced) [HTML]
Summary
The purpose of this bill is to reduce the number of opioids. It requires reports to licensing boards regarding abnormal prescribing practices; requires the Board of Pharmacy to report quarterly to various licensing boards; and permits the investigation and discipline for abnormal prescribing and dispensing of prescription drugs. The bill adds substances to Schedule I, II and IV of the Uniform Controlled Substances Act. And the bill allows licensing boards who regulate prescribers to investigate abnormal prescribing and dispensing of prescription drugs based upon information.
Title
Reducing the use of opiates
Sponsors
| Del. Tim Armstead [R] | Del. Tim Miley [D] |
History
| Date | Chamber | Action |
|---|---|---|
| 2018-01-23 | House | To House Prevention and Treatment of Substance Abuse |
| 2018-01-23 | House | Introduced in House |
| 2018-01-23 | House | To Prevention and Treatment of Substance Abuse then Judiciary |
| 2018-01-23 | House | Filed for introduction |
Same As/Similar To
SB273 (Similar To) 2018-04-23 - Chapter 46, Acts, Regular Session, 2018
